We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
-1.72%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$896M
AUM Growth
-$40.3M
Cap. Flow
-$18.6M
Cap. Flow %
-2.07%
Top 10 Hldgs %
28.01%
Holding
188
New
5
Increased
33
Reduced
88
Closed
11

Top Buys

Rank Stock Value
1
WPP icon
WPP
WPP
+$3.66M
2
PPG icon
PPG Industries
PPG
+$2.14M
3
NTR icon
Nutrien
NTR
+$1.9M
4
WY icon
Weyerhaeuser
WY
+$1.04M
5
USB icon
US Bancorp
USB
+$1.01M

Top Sells

Rank Stock Value
1
COL
Rockwell Collins
COL
+$4.88M
2
XRAY icon
Dentsply Sirona
XRAY
+$4.24M
3
VOD icon
Vodafone
VOD
+$3.54M
4
MSFT icon
Microsoft
MSFT
+$2.91M
5
AGU
Agrium
AGU
+$1.96M

Sector Composition

Rank Sector Weight
1 Technology 22.7%
2 Healthcare 16.8%
3 Industrials 10.59%
4 Financials 10.31%
5 Consumer Staples 10.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWX
26
DELISTED
Time Warner Inc
TWX
$13.7M 1.53%
145,211
+1,103
+0.8% +$104K
EBAY icon
27
eBay
EBAY
$52.1B
$13.4M 1.5%
333,377
+3,451
+1% +$143K
ZBH icon
28
Zimmer Biomet
ZBH
$18.5B
$13.2M 1.47%
124,768
+4,952
+4% +$575K
JNJ icon
29
Johnson & Johnson
JNJ
$643B
$13M 1.45%
101,323
-4,353
-4% -$588K
UN
30
DELISTED
Unilever NV New York Registry Shares
UN
$12.7M 1.41%
224,707
-235
-0.1% -$12.9K
RDS.B
31
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$11.9M 1.32%
181,011
-14,420
-7% -$970K
USB icon
32
US Bancorp
USB
$100B
$11.6M 1.29%
229,747
+18,454
+9% +$1.01M
PG icon
33
Procter & Gamble
PG
$347B
$11.5M 1.29%
145,505
-4,987
-3% -$416K
BC icon
34
Brunswick
BC
$5.33B
$11.3M 1.26%
190,782
+8,367
+5% +$495K
DIS icon
35
Walt Disney
DIS
$172B
$11.1M 1.24%
110,639
+4,493
+4% +$477K
SNY icon
36
Sanofi
SNY
$109B
$10.7M 1.19%
266,849
+15,800
+6% +$657K
GILD icon
37
Gilead Sciences
GILD
$167B
$10.5M 1.17%
138,935
+2,967
+2% +$236K
WPP icon
38
WPP
WPP
$4.59B
$10.2M 1.13%
127,670
+41,200
+48% +$3.66M
CVX icon
39
Chevron
CVX
$374B
$10.1M 1.13%
88,949
-4,832
-5% -$578K
NVS icon
40
Novartis
NVS
$304B
$9.79M 1.09%
135,094
+3,465
+3% +$264K
SNPS icon
41
Synopsys
SNPS
$73.5B
$9.72M 1.08%
116,761
-2,245
-2% -$197K
GLW icon
42
Corning
GLW
$108B
$9.42M 1.05%
337,891
-7,725
-2% -$238K
UL icon
43
Unilever
UL
$144B
$9.03M 1.01%
144,399
+3,446
+2% +$210K
XRAY icon
44
Dentsply Sirona
XRAY
$2.7B
$8.29M 0.92%
164,702
-71,952
-30% -$4.24M
ALB icon
45
Albemarle
ALB
$13.3B
$8.05M 0.9%
86,755
+7,210
+9% +$794K
TRMB icon
46
Trimble
TRMB
$13.6B
$6.62M 0.74%
184,413
+110
+0.1% +$4.43K
AMGN icon
47
Amgen
AMGN
$212B
$6.44M 0.72%
37,757
-1,162
-3% -$213K
CTSH icon
48
Cognizant
CTSH
$23.8B
$6.4M 0.71%
79,548
+1,853
+2% +$146K
MDLZ icon
49
Mondelez International
MDLZ
$80.2B
$6.04M 0.67%
144,635
-1,772
-1% -$77K
TMO icon
50
Thermo Fisher Scientific
TMO
$214B
$5.91M 0.66%
28,617
-1,084
-4% -$228K

Similar funds

Grandfield & Dodd's Q1 2018 Portfolio in Review

As of Q1 2018, Grandfield & Dodd held 188 positions worth $896M, down 4.3% from $937M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Grandfield & Dodd's Q1 2018 filing shows 5 new, 33 increased, 88 reduced and 11 closed positions. Its largest new stake was Nutrien: 37,980 shares worth $1.79M. The largest sale was Rockwell Collins, an estimated $4.88M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Grandfield & Dodd's largest Q1 2018 buy was Nutrien: 37,980 shares worth $1.79M.
  • Grandfield & Dodd added most to WPP in Q1 2018, an estimated $3.66M increase.
  • Grandfield & Dodd's biggest Q1 2018 reduction was Rockwell Collins, cutting an estimated $4.88M.
  • Grandfield & Dodd fully exited Agrium in Q1 2018, selling an estimated $1.96M.
  • Grandfield & Dodd's ten largest holdings make up 28% of its $896M portfolio in Q1 2018.
  • Grandfield & Dodd opened 5 new positions and closed 11 in Q1 2018.
  • Grandfield & Dodd's portfolio value fell 4.3% quarter-over-quarter to $896M.

Based on Grandfield & Dodd's 13F filing for Q1 2018, filed 4 May 2018.